technical update, page-161

Buzzinround :

"Twin you didn't answer TB's question...

"So what exactly do you think would happen if they both don't go ahead, which was the point of my post....."


The chance of them both not going ahead is about 5% IMO

That is why ADO is different to drug companies - ADO have another 100 odd testing companies as well as many other fruitful industries outside healthcare to pursue.

I would say as per announcement that there is another 10 or so LARGE/Mid size companies that are at the pointy end - If one fell through resources would obviously increased to the customers with the nearest and largest potential for revenues.

So downside risk is better managed because of diversity and a proven working product.

And around $8m in the bank burning $1.5m after grants and no other income

Weighs up good in my books